Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Recruiting 11Completed 7Active not recruiting 3Terminated 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 29Head & Neck 17Thoracic 6Other solid neoplasm 3Sarcoma 2Breast 2Tumor-Agnostic 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Solid Tumor, Adult 1Advanced Solid Tumors 1Advanced Solid Tumor 1

Interventions

pembrolizumab 27Nivolumab 11Pemetrexed 10Cyclophosphamide 10Carboplatin 10atezolizumab 9Specimen Handling 8Cisplatin 8Ipilimumab 6Biopsy 6Injections 5tislelizumab 4spartalizumab 4fludarabine 4Vincristine 4Radiotherapy 4Proton Therapy 4Platinum 4Paclitaxel 4Drug Therapy 4Docetaxel 4Bevacizumab 41,2-diaminocyclohexaneplatinum II citrate 4durvalumab 3Trastuzumab 3Etoposide 3Cetuximab 3zimberelimab 2trametinib 2tocilizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Cetuximab × Other solid neoplasm × Clear all
NCT06715124 2026-03-02

QTX3544 in Patients With Advanced Solid Tumors With KRAS G12V Mutations

Quanta Therapeutics

Phase 1 Active not recruiting
237 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT06428500 2025-07-25

QTX3046 in Patients With KRAS G12D Mutations

Quanta Therapeutics

Phase 1 Active not recruiting
240 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT04585035 2025-03-18

Study to Evaluate D-1553 in Subjects With Solid Tumors

InventisBio Co., Ltd

Phase 1/2 Active not recruiting
180 enrolled
Other solid neoplasmThoracic

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡